Appendix 4C for Q2 2017
July 31, 2017
In accord with ASX requirements, Imagion Biosystems’ quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July, 2017, accompanied by
Category: Investor updates
Imagion Biosystems Identifies Key Operational Objectives
July 12, 2017
Imagion Biosystems Limited (Imagion, ASX:IBX), is pleased to provide shareholders and interested parties an outline of its operational objectives as it moves toward first-in-human testing
Imagion Biosystems Raises A$12 million in Initial Public Offering
June 21, 2017
Imagion Biosystems is now a publicly traded company after completing a heavily supported A$12 million initial public offering (IPO) on the Australian Securities Exchange. Imagion
Senior Scientific Financial Statements 2016
June 21, 2017
View Financial Statements for Senior Scientific LLC for the period from 1 January 2016 to 17 November 2016.
Audited Accounts to 31 December 2016
June 21, 2017
View the Consolidated Financial Statements for the period 31 December 2016.
Constitution of Imagion Biosystems Limited
June 21, 2017
View the Constitution of Imagion Biosystems Limited.
Appendix 1A — ASX Listing Application and Agreement
June 21, 2017
Appendix 1A — ASX Listing Application and Agreement is required by listing rule 1.7 to be used by an entity seeking admission to the official
Pre-Quotation Disclosure Notice
June 21, 2017
The prequotation disclosure notice contains information that is required to be provided to ASX Limited (ASX) for release to the market in connection with the
Admission and Commencement of Official Quotation
June 21, 2017
Imagion Biosystems was admitted to the Official List of ASX Limited (ASX) today. View the ASX Notice of Imagion Biosystems Limited — Admission and Commencement